VIP943 Is a Novel CD123 Antibody Drug Conjugate with in Vitro and In Vivo Efficacy in Acute Myeloid Leukemia (AML) Models

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.5955-5956
Main Authors: Stelte-Ludwig, Beatrix, Clemens, George, Schomber, Tibor, Frigault, Melanie M., Johnson, Amy J., Lerchen, Hans-Georg, Izumi, Raquel, Hamdy, Ahmed
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-167556